A Comparative Clinical Study to evaluate the efficacy of Nasya karma with Mahamasa taila (Niramisa) and Ksheerabala avartana taila in the management of visvaci vata with special reference to Brachial Neuralgia
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- To compare the efficacies of Nasya karma with MahāmāṣhaTaila (nirāmiṣā) group and
研究概览
简要总结
Brachial neuralgia is a rare disorder affecting the brachial plexus, characterised by severe burning
pain in the shoulder and upper arm that awakens the patient from sleep accompanied with
upper arm weakness. Brachial neuralgia presents as an acute brachial plexopathy of probable inflammatory origin. Severe
shoulder pain precedes the appearance of a patchy upper brachial plexus lesion, with motor and
sensory involvement. There is no specific treatment and recovery is often incomplete; it may
reoccur in about 25% and there is a rare autosomal dominant hereditary form.
It is multifocal, immune-mediated inflammatory process that involves the peripheral nerves. More
common causes that have been reported in the literature include infection, whether bacterial,
parasitic or viral. Other conditions that predispose patients to developing brachial neuralgia are
expose to surgery, an anaesthesia, rheumatic diseases such as connective tissue disorders, systemic
lupus erythematosus, temporal arteritis, and polyarteritis nodosa. Trauma to the shoulder girdle and
stressful exercise are other determining factors.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients aged between 20 to 60 years.
- •Patients presenting with the signs and symptoms of viÅ›vaÌ„cÄ«.
- •Patients presenting with the signs and symptoms of Brachial neuralgia.
- •Patients who are eligible for Nasya karma.
排除标准
- •1.Patients aged between below 20 and above 60 years.
- •2.Patients with Uncontrolled Diabetes and Hypertension.
- •3.Patients with Ankylosing Spondylitis.
- •4.Patients associated with any other major systemic illness like Tuberculosis, Cancer.
- •5.Patients who are not eligible for Nasya karma.
- •6.Patients who are not willing to give the consent.
结局指标
主要结局
To compare the efficacies of Nasya karma with MahāmāṣhaTaila (nirāmiṣā) group and
时间窗: At baseline after after completion of treatment 14th day, 4 weeks
Ksheerabala avartana taila group in the management of viśvācī (Brachial Neuralgia).
时间窗: At baseline after after completion of treatment 14th day, 4 weeks
次要结局
- To compare the efficacies of Nasya karma with MahāmāṣhaTaila (nirāmiṣā) group and(Ksheerabala avartana taila group in the management of viśvācī (Brachial Neuralgia).)
- To compare the efficacies of Nasya karma with MahāmāṣhaTaila (nirāmiṣā) group and(Ksheerabala avartana taila group in the management of viśvācī (Brachial Neuralgia).)
研究者
Dr.D. Priyadarshini
Sri Venkateswara Ayurvedic College and Hospital
